Table of Contents
Biologics and cellular therapies for musculoskeletal injuries—including hard tissue (i.e., bone) and soft tissue (i.e., cartilage, ligaments, and tendons)—represent a billion dollar market that is showing the potential for continued growth. Over the forecast period covered in this report, the estimated value of the U.S. market for orthopedic biologic and tissue engineered products is expected to grow by approximately $984.4 million at a compound annual growth rate (CAGR) of 8.2% to $3,014.1 million; of this holistic market, biologic and cellular therapies for hard musculoskeletal tissue are forecasted to grow at a CAGR of 7.2%, while soft musculoskeletal tissue products will grow at a CAGR of 10.6%.
This report will cover:
emerging and existing cellular therapies for hard and soft musculoskeletal tissue repair and regeneration;
key factors influencing the growth of individual product markets;
estimated market shares and sales among major U.S. suppliers
companies and biotech firms developing novel cellular therapies; and,
major supplier product portfolio analysis in individual product markets.
The scope of the analysis of this report covers companies developing and distributing biologics and novel cellular therapeutics for the treatment of musculoskeletal injuries. Hard tissue musculoskeletal products covered in this report include bone allograft and machined bone, demineralized bone matrix, growth factor-based bone grafts, cellular bone matrices, and select other biologics. Soft tissue musculoskeletal products covered by this report include cartilage regeneration and repair products, ligament and tendon repair technologies, and meniscus repair and regeneration products.
Get Industry Insights. Simply.
Talk to Ahmad
+1 718 618 4302
The global orthobiologics market is expected to reach USD 10.2 billion by 2025, according to a new study by Grand View Research, Inc. The orthobiologics market is predominantly driven by the increasing ...
Description General Report Contents - Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends - Market Drivers & Limiters for each chapter segment - Competitive Analysis for each chapte ...
KEY FINDINGS The orthobiologics global market is anticipated to grow from $ 6596 million in 2016 to $ 12019 million by 2025. The market is expected to grow at a CACR of 6.97% between 2016 -2027. The base ...